Open Actively Recruiting

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

About

Brief Summary

To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.

Study Type

Observational

Phase

Phase 4

Eligibility

Gender

All

Healthy Volunteers

Yes

Minimum Age

N/A

Maximum Age

N/A

Inclusion Criteria:

Currently using one or more topical glaucoma antihypertensives
Self-described symptoms of ocular surface discomfort
Xiidra is being prescribed as part of the subject's standard care

Exclusion Criteria:

History of glaucoma filtration surgery, history of ocular surface surgery (pterygium, conjunctivoplasty, etc.),
current use of topical cyclosporine
current use of topical steroids
incisional ocular surgery within 6 months

Not a fit? Find another study